Back to Search
DANIEL HILLEMAN, PHARM.D.
PHARM.D.
Pharmacotherapy Pharmacist
NPI: 1770567760Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
9456(NE)
Research & Publications (20)
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.
PMID 19657399·Int J Chron Obstruct Pulmon Dis·2009
1-meta
Clinical and economic evaluation of the Trellis-8 infusion catheter for deep vein thrombosis.
PMID 18295697·J Vasc Interv Radiol·2008
4-observational
Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.
PMID 17963464·Pharmacotherapy·2007
4-observational
Cost considerations with tight glycemic control in the acute care setting.
PMID 17395033·Semin Thorac Cardiovasc Surg·2006
6-review
Pharmacological management of atrial fibrillation following cardiac surgery.
PMID 16259524·Am J Cardiovasc Drugs·2005
8-other
Angiotensin-converting enzyme inhibitors and stroke risk: benefit beyond blood pressure reduction?
PMID 15338854·Pharmacotherapy·2004
6-review
Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia.
PMID 15338855·Pharmacotherapy·2004
6-review
Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery.
PMID 14769721·Chest·2004
4-observational
Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
PMID 13678474·Curr Med Res Opin·2003
4-observational
Reteplase for dysfunctional hemodialysis catheter clearance.
PMID 12587800·Pharmacotherapy·2003
3-trial
Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
PMID 11794432·Pharmacotherapy·2002
1-meta
Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
PMID 11349745·Pharmacotherapy·2001
6-review
Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
PMID 11494095·J Hum Hypertens·2001
4-observational
Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease.
PMID 11310513·Pharmacotherapy·2001
3-trial
Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease.
PMID 11714215·Pharmacotherapy·2001
4-observational
Role of angiotensin-converting-enzyme inhibitors in the treatment of hypertension.
PMID 11030017·Am J Health Syst Pharm·2000
6-review
Pharmacoeconomic assessment of HMG-CoA reductase inhibitor therapy: an analysis based on the CURVES study.
PMID 10907971·Pharmacotherapy·2000
3-trial
Prevalence, treatment, and control of hypertension in residents of skilled nursing facilities.
PMID 18454588·Consult Pharm·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3006 WEBSTER STREET, CREIGHTON UNIVERSITY CARDIAC CENTER
OMAHA, NE 68131 - Phone
- (402) 280-4288
Quick Facts
- NPI
- 1770567760
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile